Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Score 2
2018 pubmed 11 citations

Effect of Kisspeptin-10 on plasma luteinizing hormone concentrations and follicular dynamics during the luteal phase in cattle.

Leonardi. Carlos E P CEP; Dias. Fernanda C F FCF; Adams. Gregg P GP; Singh. Jaswant J

Key Findings

  • IV kisspeptin‑10 caused a quicker and higher LH spike than IM injection
  • Higher doses (15 mg) produced larger LH peaks than 10 mg or saline
  • Kisspeptin‑10 increased dominant follicle diameter but did not lead to ovulation
  • GnRH was far more effective at inducing ovulation than kisspeptin

Practical Outcomes

  • For self‑experimenters, kisspeptin can boost LH, but the effect is modest and timing‑dependent; current cattle doses are unlikely to cause ovulation in humans without much higher or repeated dosing. It may be useful as a research tool rather than a ready‑to‑use protocol.

Summary

Kisspeptin‑10 given to cows raised blood LH levels and made the main follicle a bit bigger, but the doses used didn’t trigger ovulation during the luteal phase.

Abstract

Two experiments were carried out to determine the effect of Kisspeptin-10 on plasma LH concentrations and follicular dynamics during the luteal phase in cattle. We tested the hypothesis that a single treatment of Kisspeptin-10 will increase plasma LH concentration and the diameter of the dominant follicle, and induce ovulation during the luteal phase of the estrous cycle in cattle. In the Experiment 1, Hereford-cross heifers (n = 28, 14-16 mo) were given PGF2α im to induce luteolysis and ovulation. On Day 5 (Day 0 = ovulation), a new follicular wave was induced by ultrasound-guided follicular ablation. Heifers were treated on Day 10 (4 days after wave emergence) with 100 μg GnRH im (n = 9), 2 mL saline im (n = 7), 1 mg Kisspeptin-10 im (Kp im, n = 6) or 1 mg Kisspeptin-10 iv (Kp iv; n = 6). Blood samples were collected at -60, -15, 0, 5, 15min (0 min = time of injection) and every 15 min thereafter until 3 h. Transrectal ovarian ultrasonography was performed at 12 h intervals from Day 10-14. In Experiment 2, non-lactating beef cows on Day 5 were treated with 100 μg GnRH im (n = 9), saline im (n = 5), 10 mg of Kisspeptin-10 iv (Kp 10 mg; n = 5) or 15 mg of Kisspeptin-10 iv (Kp 15 mg; n = 5). Blood samples were collected at -15, 0, 15, 30, 60, 120, 180 min and twice daily ovarian ultrasonography was done from Day 5-10. In Expt 1, plasma LH concentrations increased for 1 h following Kp iv administration. The peak concentration occurred at 15 min and was higher in the Kp iv group than in the Kp im group (P = 0.01). The LH peak was 3.5-folds higher in the GnRH group than the Kp iv group (P < 0.0001). In Expt 2, GnRH induced higher (P < 0.001) plasma LH concentrations for all time-points than other groups. Kp 15 mg at peak (15min), 30 and 60 min induced higher (P < 0.0001) plasma LH concentrations than Kp 10 mg and saline. Kisspeptin-treated animals did not ovulate in either experiment while GnRH induced ovulation (n = 5/9 in Expt 1; 9/9 in Expt 2). The diameter of the dominant follicle was greater (P = 0.02) at 12-48 h after kisspeptin treatment (Kp groups combined) than the Saline group in Expt 2. In conclusion, Kisspeptin-10 increased plasma LH concentrations and follicle size, and although plasma LH concentrations were higher after iv than im administration, but at the doses used, Kisspeptin-10 did not induce ovulation during the luteal phase in cattle.

Study Information

Provider

pubmed

Year

2018

Date

2018-06-26T00:00:00.000Z

DOI

10.1016/j.theriogenology.2018.06.023

Citations

11

References

41